SK167396A3 - Improved methods for the determination and adjustment of prolactin daily rhythms - Google Patents

Improved methods for the determination and adjustment of prolactin daily rhythms Download PDF

Info

Publication number
SK167396A3
SK167396A3 SK1673-96A SK167396A SK167396A3 SK 167396 A3 SK167396 A3 SK 167396A3 SK 167396 A SK167396 A SK 167396A SK 167396 A3 SK167396 A3 SK 167396A3
Authority
SK
Slovakia
Prior art keywords
prolactin
subject
level
key
healthy subjects
Prior art date
Application number
SK1673-96A
Other languages
English (en)
Slovak (sk)
Inventor
Anthony H Cincotta
Albert H Meier
Original Assignee
Ergo Science Inc
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ergo Science Inc, Univ Louisiana State filed Critical Ergo Science Inc
Publication of SK167396A3 publication Critical patent/SK167396A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Transmission Device (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
SK1673-96A 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms SK167396A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26455894A 1994-06-23 1994-06-23
PCT/US1995/009061 WO1996000396A1 (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms

Publications (1)

Publication Number Publication Date
SK167396A3 true SK167396A3 (en) 1997-11-05

Family

ID=23006606

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1673-96A SK167396A3 (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms

Country Status (14)

Country Link
EP (1) EP0769148A1 (xx)
JP (1) JPH10503842A (xx)
AU (1) AU3101395A (xx)
BR (1) BR9508366A (xx)
CA (1) CA2192855A1 (xx)
CZ (1) CZ378796A3 (xx)
FI (1) FI965146A (xx)
HU (1) HUT76976A (xx)
IL (1) IL114300A0 (xx)
MX (1) MX9700225A (xx)
NO (1) NO965507L (xx)
SK (1) SK167396A3 (xx)
WO (1) WO1996000396A1 (xx)
ZA (1) ZA955192B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
EP2217073B1 (en) 2007-06-21 2019-10-09 VeroScience LLC Method of treating metabolic disorders and depression with dopamine receptor agonists
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
US5066526A (en) * 1987-11-19 1991-11-19 Exxon Chemical Patents Inc. Thermoplastic films for use in stretch/cling applications
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Also Published As

Publication number Publication date
NO965507D0 (no) 1996-12-20
HU9603543D0 (en) 1997-02-28
JPH10503842A (ja) 1998-04-07
HUT76976A (hu) 1998-01-28
BR9508366A (pt) 1997-09-30
EP0769148A1 (en) 1997-04-23
NO965507L (no) 1997-02-11
ZA955192B (en) 1996-05-07
AU3101395A (en) 1996-01-19
FI965146A0 (fi) 1996-12-20
CA2192855A1 (en) 1996-01-04
FI965146A (fi) 1996-12-20
CZ378796A3 (en) 1997-09-17
MX9700225A (es) 1997-04-30
WO1996000396A1 (en) 1996-01-04
IL114300A0 (en) 1995-10-31

Similar Documents

Publication Publication Date Title
US5585347A (en) Methods for the determination and adjustment of prolactin daily rhythms
US5716962A (en) Process for therapeutically modifying and resetting prolactin rhythm with a dopamine agonist
US5877183A (en) Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
EP0440333B1 (en) Use of prolactin-inhibiting compounds for resetting the prolactin circadian rhythm
US5626860A (en) Method for regulating metabolism with dopamine beta hydroxylase inhibitors
JPH11507385A (ja) グルコース代謝の調節法
AU2259092A (en) Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
JPH10507159A (ja) 脂質代謝疾患の治療に対するピレンゼピン、メチルスコポラミン及び他のムスカリン性受容体アンタゴニストの投与法
EP0808164B1 (en) Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity
PT934069E (pt) Método e composição para o tratamento de perturbações do metabolismo dos lípidos e glucose
US5830895A (en) Methods for the determination and adjustment of prolactin daily rhythms
US6004972A (en) Therapeutic process for the treatment of the pathologies of type II diabetes
JP2000513337A (ja) ドーパミン及びセロトニンアゴニストによる脂質及びグルコース代謝障害の治療
JP2007291139A (ja) 脂質及びグルコースの代謝疾患治療剤及び組成物
RU2104698C1 (ru) Способ лечения патологических отклонений при диабете типа ii
SK167396A3 (en) Improved methods for the determination and adjustment of prolactin daily rhythms
WO1997017083A1 (en) Method for treating obesity and type ii diabetes by adjusting the circadian rhythm of human growth hormone
MXPA97009573A (en) Method for regulating metabolism with beta hidroxil dopamine inhibitors